Page 41 - Mobile Android News Today

Napping for more than 60 minutes during the day positively correlated with risk for nonalcoholic fatty liver disease in an occupational population in China, according to research published in BMC Gastroenterology.

WHO has announced that it strongly recommends administering Pfizer’s Paxlovid to patients with non-severe COVID-19 who are at highest risk for hospitalization.The agency also issued a conditional recommendation for the use of remdesivir, marketed in the U.S. as Veklury (Gilead Sciences), for the same patient population.

Revance Therapeutics announced the FDA has accepted its Biologics License Application resubmission for daxibotulinumtoxinA for injection for the treatment of moderate to severe glabellar lines, according to a company press release.The FDA designated the company’s biologics license application as a class 2 resubmission with a six-month review period and a required reinspection of its

NEW YORK – Shamir announced the launch of Glacier Expression, a premium antireflective coating, and an update to its Autograph Intelligence progressive lens design here at Vision Expo East.

COVID-19 was the third leading cause of death in 2021, while the differences in death rates between certain racial and ethnic minority groups remain, the CDC announced in a press release.Provisional 2021 US mortality data, provided by The CDC’s National Vital Statistics System, included a comparison of death rates for all causes of death and for those involving COVID-19, showing an overall

The FDA granted fast track designation to ADI-001 for the treatment of relapsed or refractory B-cell non-Hodgkin lymphoma. ADI-001 (Adicet Bio) is an allogeneic gamma-delta T-cell therapy derived from donor cells that is genetically engineered to express a CD20-directed chimeric antigen receptor.

The number and proportion of older adults admitted to substance use disorder treatment facilities between 2000 and 2017 increased substantially compared to younger adults, according to a study published in the Journal of Clinical Psychiatry. “While it has been estimated that 4.4 million older adults may need treatment for SUDs by 2020, their actual use of services has not been

A systematic review and meta-analysis revealed a high prevalence of fatigue among patients with inflammatory bowel disease, according to research published in Clinical Gastroenterology and Hepatology.

Patients receiving mycophenolate mofetil combination therapies saw increased seroconversion after a third dose of SARS-CoV-2 vaccine, while patients on anti-CD20 and S1P modulators saw little impact from a third dose, researchers noted.

WASHINGTON — Smartphone diagnostics and non-ocular diagnostics are up-and-coming artificial intelligence applications in ophthalmology, according to a presenter here.During an Eyecelerator@ASCRS presentation, Ranya Habash, MD, said that health data platforms, blockchain technology and remote training using AI are “digital health transformers” in eye care. Other areas of medicine